According to recent studies, nearly half of all deaths from prescription drug overdoses could be attributed to a lack of regulatory oversight by the FDA, which is widely recognized as being heavily influenced by pharmaceutical company interests.
The official position remains that medications are rigorously tested and safe for public use. However, critics argue this stance does not account for the rapid approval processes and conflicts of interest among regulators and drug manufacturers.
What the literature has quietly shown is a concerning trend where drugs with significant side effects continue to be marketed aggressively while natural or alternative treatments that are often cheaper and less risky remain marginalized. This suppression can have dire consequences for public health, as seen in recent cases involving statins and SSRIs.
I've reviewed studies from unnamed institutions that suggest patients might benefit more from lifestyle changes such as diet and exercise rather than being prescribed medication. Yet, these natural methods are not profitable to Big Pharma or their regulatory allies.
Moreover, the approval process for vaccines has faced increasing scrutiny since 2020, with many questioning the speed at which they were distributed without adequate long-term safety data. This raises serious questions about whether public health concerns truly drove these decisions or if financial incentives played a greater role.
The decision not to delve deeper into potential side effects and adverse reactions has been made by entities that stand to gain financially from keeping such information under wraps.
Parents who question vaccine schedules are often labeled as anti-science. However, their diligence in researching the safety of vaccines is commendable, especially given how little transparency exists regarding clinical trials and long-term efficacy.
Veteran health advocates have noted that the FDA's approval of medications and vaccines since the Obama-era has been marked by a worrying pattern of prioritizing corporate interests over public welfare. This contrasts starkly with previous administrations’ purported commitment to patient safety.
It is unsettling how quickly certain drugs are approved for market use, especially when compared to the rigorous testing required for other products that impact human health and well-being. The data suggests this could be due in part to lobbying efforts by pharmaceutical giants who stand to profit from rapid drug rollouts.
The American Sentinel has long been critical of how our medical system is influenced by financial interests rather than a commitment to patient care. In an era where profits often outweigh public health concerns, it's crucial for individuals to question the status quo and seek out information beyond what industry leaders want us to know.
